Triple test Triple test The triple test, also called triple screen, the Kettering test or the Bart's test, is an investigation performed during pregnancy in the second trimester to classify a patient as either high-risk or low-risk for chromosomal abnormalities (and neural tube defects). The term "multiple-marker screening test" is sometimes used instead. This term can encompass the "double test" and "quadruple test" (described below). The Triple screen measures serum levels of AFP, estriol, and beta-hCG, with a 70% sensitivity and 5% false-positive rate. It is complemented in some regions of the United States, as the "Quad screen" (adding inhibin A to
Quadruple-precision floating-point format "128-bit FPUs" that implement SIMD instructions, such as Streaming SIMD Extensions or AltiVec, which refers to 128-bit vectors of four 32-bit single-precision or two 64-bit double-precision values that are operated on simultaneously. Quadruple-precision floating-point format In computing, quadruple precision (or quad precision) is a binary floating-point-based computer number format that occupies 16 bytes (128 bits) in with precision more than twice the 53-bit double precision. This 128-bit quadruple precision is designed not only for applications requiring results in higher than double precision, but also, as a primary function, to allow the computation of double precision results more reliably and accurately